124 related articles for article (PubMed ID: 28082737)
1. Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL.
Serafin V; Lissandron V; Buldini B; Bresolin S; Paganin M; Grillo F; Andriano N; Palmi C; Cazzaniga G; Marmiroli S; Conter V; Basso G; Accordi B
Leukemia; 2017 Apr; 31(4):1007-1011. PubMed ID: 28082737
[No Abstract] [Full Text] [Related]
2. Recruitment of calcineurin to the TCR positively regulates T cell activation.
Dutta D; Barr VA; Akpan I; Mittelstadt PR; Singha LI; Samelson LE; Ashwell JD
Nat Immunol; 2017 Feb; 18(2):196-204. PubMed ID: 27941787
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and pharmacological evaluation of novel benzothiazole derivatives targeting LCK in acute lymphoblastic leukemia.
Chen Y; Zhang K; Tan J; Fan Z; Fu Y; Li X; Liu B; Wang G
Bioorg Chem; 2024 Mar; 144():107180. PubMed ID: 38335758
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL.
Nel AE; Hanekom C; Hultin L
J Immunol; 1991 Sep; 147(6):1933-9. PubMed ID: 1716287
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.
Yu CL; Jove R; Burakoff SJ
J Immunol; 1997 Dec; 159(11):5206-10. PubMed ID: 9548458
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
[TBL] [Abstract][Full Text] [Related]
7. Cr(VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck.
O'Hara KA; Vaghjiani RJ; Nemec AA; Klei LR; Barchowsky A
Biochem J; 2007 Mar; 402(2):261-9. PubMed ID: 17078813
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
9. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
[TBL] [Abstract][Full Text] [Related]
10. The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activity.
Lund TC; Coleman C; Horvath E; Sefton BM; Jove R; Medveczky MM; Medveczky PG
Cell Signal; 1999 Nov; 11(11):789-96. PubMed ID: 10617281
[TBL] [Abstract][Full Text] [Related]
11. 7,12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-gamma 1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium.
Archuleta MM; Schieven GL; Ledbetter JA; Deanin GG; Burchiel SW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6105-9. PubMed ID: 8327490
[TBL] [Abstract][Full Text] [Related]
12. Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia.
Ivanyi P; Morgan M; Piao W; Ukena SN; Steube K; Ganser A; Franzke A
Cell Oncol; 2010; 32(1-2):101-8. PubMed ID: 20208138
[TBL] [Abstract][Full Text] [Related]
13. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
Nyakeriga AM; Garg H; Joshi A
Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
[TBL] [Abstract][Full Text] [Related]
14. Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignancies.
Rouer E; Dreyfus F; Melle J; Ribrag V; Benarous R
Leukemia; 1993 Feb; 7(2):246-50. PubMed ID: 8426478
[TBL] [Abstract][Full Text] [Related]
15. Insulin-InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages.
Xia P; Wang S; Du Y; Huang G; Satoh T; Akira S; Fan Z
J Exp Med; 2015 Dec; 212(13):2305-21. PubMed ID: 26573296
[TBL] [Abstract][Full Text] [Related]
16. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase, and calcineurin.
Molinero LL; Fuertes MB; Fainboim L; Rabinovich GA; Zwirner NW
J Leukoc Biol; 2003 Jun; 73(6):815-22. PubMed ID: 12773514
[TBL] [Abstract][Full Text] [Related]
18. A PLC-γ1 Feedback Pathway Regulates Lck Substrate Phosphorylation at the T-Cell Receptor and SLP-76 Complex.
Belmont J; Gu T; Mudd A; Salomon AR
J Proteome Res; 2017 Aug; 16(8):2729-2742. PubMed ID: 28644030
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
[TBL] [Abstract][Full Text] [Related]
20. Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model.
Hasan MN; Queudeville M; Trentin L; Eckhoff SM; Bronzini I; Palmi C; Barth T; Cazzaniga G; te Kronnie G; Debatin KM; Meyer LH
Oncotarget; 2015 Jan; 6(3):1382-95. PubMed ID: 25682198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
